Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP

Journal of clinical and experimental hematopathology : JCEH

Volumn 54, Issue 2, 2014, Pages 149-153

  Kuriyama, Takuro ^a   Kawano, Noriaki ^a   Yamashita, Kiyoshi ^a   Ueda, Akira ^a  

^a MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; PREDNISONE; R-CHOP PROTOCOL; VINCRISTINE;

ADULT; ADVERSE EFFECTS; ANEMIA, APLASTIC; CASE REPORT; COMPLICATION; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOPROLIFERATIVE DISORDERS; TREATMENT OUTCOME;

ADULT; ANEMIA, APLASTIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; PREDNISONE; TREATMENT OUTCOME; VINCRISTINE;

EID: 84936153001     PISSN: None     EISSN: 18809952     Source Type: Journal    
DOI: 10.3960/jslrt.54.149     Document Type: Article

References (0)